If this latest cash addition was sufficient to get to the end of the phase 3 trial, would they not have said so in the announcement?
The absence of commentary to that effect has me concerned that more money will need to be raised, potentially even prior to read out. Though I'm sure they are hoping they can get to top line read out and then raise to progress through safety/FDA approval at a higher share price. Anyone else have thoughts on this?
If this latest cash addition was sufficient to get to the end of...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.035(6.73%) |
Mkt cap ! $321.4M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 50.5¢ | 47.5¢ | $314.0K | 642.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3270 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 9056 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
48.5¢ |
Change
-0.035 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 50.0¢ | 47.5¢ | 78801 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| OPT (ASX) Chart |